The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2 S Muralidar, SV Ambi, S Sekaran, UM Krishnan Biochimie 179, 85-100, 2020 | 371 | 2020 |
Role of tau protein in Alzheimer's disease: The prime pathological player S Muralidar, SV Ambi, S Sekaran, D Thirumalai, B Palaniappan International journal of biological macromolecules 163, 1599-1617, 2020 | 164 | 2020 |
Repeated fed-batch process for improving lovastatin production MS Kumar, SK Jana, V Senthil, V Shashanka, SV Kumar, AK Sadhukhan Process Biochemistry 36 (4), 363-368, 2000 | 127 | 2000 |
Withanolide induces apoptosis in HL-60 leukemia cells via mitochondria mediated cytochrome c release and caspase activation V Senthil, S Ramadevi, V Venkatakrishnan, P Giridharan, BS Lakshmi, ... Chemico-biological interactions 167 (1), 19-30, 2007 | 70 | 2007 |
Chicken egg yolk antibody (IgY) as diagnostics and therapeutics in parasitic infections–a review D Thirumalai, SV Ambi, RS Vieira-Pires, Z Xiaoying, S Sekaran, ... International journal of biological macromolecules 136, 755-763, 2019 | 53 | 2019 |
Dual epidermal growth factor receptor (EGFR)/insulin-like growth factor-1 receptor (IGF-1R) inhibitor: a novel approach for overcoming resistance in anticancer treatment R Tandon, S Kapoor, S Vali, V Senthil, D Nithya, R Venkataramanan, ... European journal of pharmacology 667 (1-3), 56-65, 2011 | 44 | 2011 |
Emerging therapeutic interventions for idiopathic pulmonary fibrosis S Chakraborty, P Chopra, SV Ambi, SG Dastidar, A Ray Expert opinion on investigational drugs 23 (7), 893-910, 2014 | 38 | 2014 |
Targeting the viral‐entry facilitators of SARS‐CoV‐2 as a therapeutic strategy in COVID‐19 S Muralidar, G Gopal, S Visaga Ambi Journal of Medical Virology 93 (9), 5260-5276, 2021 | 33 | 2021 |
Inflammation in myocardial injury-Stem cells as potential immunomodulators for myocardial regeneration and restoration S Vadivel, P Vincent, S Sekaran, SV Ambi, S Muralidar, V Selvaraj, ... Life sciences 250, 117582, 2020 | 19 | 2020 |
Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase P Chopra, O Kulkarni, S Gupta, M Bajpai, V Kanoje, M Banerjee, V Bansal, ... International immunopharmacology 10 (4), 467-473, 2010 | 19 | 2010 |
Passive immunotherapy using chicken egg yolk antibody (IgY) against diarrheagenic E. coli: a systematic review and meta-analysis M Karthikeyan, ST Indhuprakash, G Gopal, SV Ambi, UM Krishnan, ... International Immunopharmacology 102, 108381, 2022 | 12 | 2022 |
RBx10080307, a dual EGFR/IGF-1R inhibitor for anticancer therapy R Tandon, V Senthil, D Nithya, V Pamidiboina, A Kumar, S Malik, T Chaira, ... European journal of pharmacology 711 (1-3), 19-26, 2013 | 10 | 2013 |
The concept of big four: road map from snakebite epidemiology to antivenom efficacy G Gopal, S Muralidar, D Prakash, A Kamalakkannan, ST Indhuprakash, ... International journal of biological macromolecules 242, 124771, 2023 | 6 | 2023 |
Synbiotics in Lung Cancer D Prakash, SK Venkataramanan, G Gopal, S Muralidar, SV Ambi Synbiotics for the Management of Cancer, 191-204, 2023 | 3 | 2023 |
Microbiome in Acute Respiratory Distress Syndrome (ARDS) G Gopal, S Muralidar, A Kamalakkannan, SV Ambi Microbiome in Inflammatory Lung Diseases, 117-134, 2022 | 3 | 2022 |
Antibody Therapy Against Antibiotic-Resistant Diarrheagenic Escherichia Coli: A Systematic Review S Thuthikkadu Indhuprakash, M Karthikeyan, G Gopal, SV Ambi, ... Immunotherapy 13 (15), 1305-1320, 2021 | 3 | 2021 |
Systematic review and meta-analysis on the efficacy of Indian polyvalent antivenom against the Indian snakes of clinical significance G Gopal, H Selvaraj, SK Venkataramanan, S Venkataraman, ... Archives of toxicology 98 (2), 375-393, 2024 | 1 | 2024 |
Future Scope of Biosimilars for the Treatment of Various Cancers A Subramanian, GD Muthukumarasamy, S Venkataraman, K Rangasamy, ... Biosimilars for Cancer Treatment: A Promising Approach, 287-309, 2024 | | 2024 |
Development of chicken egg yolk antibodies (IgY) against venom of cobra (Naja naja) and krait (Bungarus caeruleus) and a study on its neutralization potential G Gopal, M Antonysamy, S Visaga Ambi, D Thirumalai Toxin Reviews, 1-21, 2024 | | 2024 |
Synergistic Potential of Antigen-Specific Vaccines and Immunomodulatory Agents for Lung Cancer Treatment SK Venkataramanan, NS Raman, K Rangasamy, SG Ganapathy, ... Immunotherapy Against Lung Cancer: Emerging Opportunities and Challenges …, 2024 | | 2024 |